Vestal Point Capital »

Alx Oncology Hldgs shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 3.6M 6.03

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Alx Oncology Hldgs

venBio Partners
FMR
Vivo Capital
Redmile Group
Vestal Point Capital
BlackRock
MPM Oncology Impact Management
OrbiMed Advisors
Vanguard Group
Paradigm Biocapital Advisors
Millennium Management
State Street Corporation
Geode Capital Management
Morgan Stanley
Marshall Wace

View all funds holding Alx Oncology Hldgs